Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
74363608 | 7436360 | 8 | F | 20100609 | 20160719 | 20100625 | 20160802 | EXP | JP-PFIZER INC-2010075505 | PFIZER | FUKUDA, A.. THREE CASES OF RENAL CANCER COMPLICATED BY SERIOUS ADVERSE EVENTS DURING TREATMENT WITH A MOLECULAR TARGETED DRUG. JOURNAL OF JAPANESE SOCIETY OF RENAL CANCER. 2016;46:41 | 69.00 | YR | F | Y | 75.00000 | KG | 20160802 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
74363608 | 7436360 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 1X/DAY | 337.234985 | MG | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||
74363608 | 7436360 | 2 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 8 MG, 1X/DAY | 80 | MG | 0 | 8 | MG | TABLET | QD | ||||
74363608 | 7436360 | 3 | C | ATELEC | CILNIDIPINE | 1 | Oral | 10 MG, 1X/DAY | 100 | MG | 0 | 10 | MG | TABLET | QD | ||||
74363608 | 7436360 | 4 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 20 MG, 2X/DAY | 400 | MG | 0 | 20 | MG | TABLET | BID | ||||
74363608 | 7436360 | 5 | C | REBAMIPIDE | REBAMIPIDE | 1 | Oral | 100 MG, 2X/DAY | 2000 | MG | 0 | 100 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
74363608 | 7436360 | 1 | Renal cell carcinoma |
74363608 | 7436360 | 2 | Hypertension |
74363608 | 7436360 | 3 | Hypertension |
74363608 | 7436360 | 4 | Gastritis |
74363608 | 7436360 | 5 | Gastritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
74363608 | 7436360 | LT |
74363608 | 7436360 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
74363608 | 7436360 | Disease progression | |
74363608 | 7436360 | Guillain-Barre syndrome | |
74363608 | 7436360 | Renal cell carcinoma | |
74363608 | 7436360 | Tumour lysis syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
74363608 | 7436360 | 1 | 20100601 | 20100614 | 0 | |
74363608 | 7436360 | 2 | 20100531 | 20100622 | 0 | |
74363608 | 7436360 | 3 | 20100531 | 20100622 | 0 | |
74363608 | 7436360 | 4 | 20100531 | 20100622 | 0 | |
74363608 | 7436360 | 5 | 20100531 | 20100622 | 0 |